Walleye Trading
GYRE icon

Walleye Trading’s Gyre Therapeutics GYRE Stock Holding History

Walleye Trading’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,801
Closed -$56K – 5547
2021
Q3 		$56K Buy
+1,801
New +$59.3K ﹤0.01% 4603
2019
Q2 		– Sell
-1,479
Closed -$90K – 4230
2019
Q1 		$90K Buy
+1,479
New +$95K ﹤0.01% 3502
2018
Q4 		– Sell
-8,019
Closed -$648K – 4906
2018
Q3 		$648K Buy
8,019
+1,615
+25% +$128K ﹤0.01% 2587
2018
Q2 		$560K Sell
6,404
-6,031
-49% -$1.06M ﹤0.01% 2740
2018
Q1 		$2.41M Buy
+12,435
New +$2.32M 0.01% 1048
2015
Q3 		– Sell
-3
Closed -$6K – 5179
2015
Q2 		$6K Buy
+3
New +$6.01K ﹤0.01% 4442

Other funds holding GYRE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Walleye Trading's GYRE Position: Q4 2021 in Review

Walleye Trading sold out of Gyre Therapeutics (GYRE) in Q4 2021, closing a stake of 1,801 shares — an estimated $56K sold.

Walleye Trading first reported a position in GYRE in Q2 2015 and held it in 6 quarters. The position peaked at $2.41M in Q1 2018. 51 funds tracked by Wall St. Rank hold GYRE as of Q4 2021.

  • Walleye Trading reported no remaining Gyre Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Walleye Trading sold 1,801 Gyre Therapeutics shares in Q4 2021, an estimated $56K.
  • Walleye Trading first reported a position in Gyre Therapeutics in Q2 2015 and held it in 6 quarters.
  • Walleye Trading's Gyre Therapeutics position peaked at $2.41M in Q1 2018.
  • 51 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q4 2021.

Based on Walleye Trading's 13F filing for Q4 2021, filed 14 Feb 2022.